These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. T cell-mediated terminal maturation of dendritic cells, a critical transition into fully potent antigen presenting cells. Takashima A; Kitajima T Pathol Biol (Paris); 1998 Jan; 46(1):53-60. PubMed ID: 9769937 [TBL] [Abstract][Full Text] [Related]
10. GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response. Eksioglu EA; Mahmood SS; Chang M; Reddy V Exp Hematol; 2007 Aug; 35(8):1163-71. PubMed ID: 17562355 [TBL] [Abstract][Full Text] [Related]
11. In vivo activation of mouse dendritic epidermal T cells in sites of contact dermatitis. Kaminski MJ; Bergstresser PR; Takashima A Eur J Immunol; 1993 Jul; 23(7):1715-8. PubMed ID: 8325341 [TBL] [Abstract][Full Text] [Related]
12. T cell-dependent loss of proliferative responsiveness to colony-stimulating factor-1 by a murine epidermal-derived dendritic cell line, XS52. Kitajima T; Ariizumi K; Bergstresser PR; Takashima A J Immunol; 1995 Dec; 155(11):5190-7. PubMed ID: 7594529 [TBL] [Abstract][Full Text] [Related]
13. Establishment of a cell line with features of early dendritic cell precursors from fetal mouse skin. Girolomoni G; Lutz MB; Pastore S; Assmann CU; Cavani A; Ricciardi-Castagnoli P Eur J Immunol; 1995 Aug; 25(8):2163-9. PubMed ID: 7664779 [TBL] [Abstract][Full Text] [Related]
14. Circulating CD3+/T cell receptor V gamma 3+ fetal murine thymocytes home to the skin and give rise to proliferating dendritic epidermal T cells. Payer E; Elbe A; Stingl G J Immunol; 1991 Apr; 146(8):2536-43. PubMed ID: 1826696 [TBL] [Abstract][Full Text] [Related]
15. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Vremec D; Lieschke GJ; Dunn AR; Robb L; Metcalf D; Shortman K Eur J Immunol; 1997 Jan; 27(1):40-4. PubMed ID: 9021996 [TBL] [Abstract][Full Text] [Related]
16. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor. Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814 [TBL] [Abstract][Full Text] [Related]